Cargando…

DNA-protein biomarkers for immunotherapy in the era of precision oncology

The use of biomarkers to guide patient and therapy selection has gained much attention to increase the scope and complexity of targeted therapy options and immunotherapy. Clinical trials provide a basis for discovery of biomarkers, which can then aid in development of new drugs. To that end, samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Binnari, Kang, So Young, Kim, Kyoung-Mee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829578/ https://www.ncbi.nlm.nih.gov/pubmed/33153244 http://dx.doi.org/10.4132/jptm.2020.09.23

Ejemplares similares

Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer
por: Kim, Binnari, et al.
Publicado: (2023)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
por: Kim, Binnari, et al.
Publicado: (2020)

Circulating tumor DNA analysis in the era of precision oncology
por: Said, Rabih, et al.
Publicado: (2020)

Cancer Panel Assay for Precision Oncology Clinic: Results from a 1-Year Study
por: Kwon, Dohee, et al.
Publicado: (2019)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Clinical Circulating Tumor DNA Testing for Precision Oncology
por: Kim, Hyunji, et al.
Publicado: (2023)

Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
por: Moore, Donald C., et al.
Publicado: (2023)

Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era
por: Kalfeist, Laura, et al.
Publicado: (2022)

Targeting cancer metabolism in the era of precision oncology
por: Stine, Zachary E., et al.
Publicado: (2021)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Management of Advanced Prostate Cancer in the Precision Oncology Era
por: Gillette, Claire M., et al.
Publicado: (2023)

Immunotherapy – The New Era of Oncology
por: Kansy, Benjamin, et al.
Publicado: (2018)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology
por: Nifosì, Antonio Fabrizio, et al.
Publicado: (2019)

Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures
por: Floridi, Chiara, et al.
Publicado: (2022)

Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
por: Alghamdi, Saad, et al.
Publicado: (2023)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
por: Zhang, Jiajia, et al.
Publicado: (2018)

Combining precision oncology and immunotherapy by targeting the MALT1 protease
por: Mempel, Thorsten R, et al.
Publicado: (2022)

Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
por: Choi, Sangjoon, et al.
Publicado: (2022)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
por: Samuel, Younan, et al.
Publicado: (2023)

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
por: Rossi, Giovanni, et al.
Publicado: (2020)

Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa
por: Kim, Binnari, et al.
Publicado: (2020)

Individualized prognostic calculators in the precision oncology era
por: Taylor, Jeremy M.G., et al.
Publicado: (2019)

Artificial Intellgence in the Era of Precision Oncological Imaging
por: Cellina, Michaela, et al.
Publicado: (2022)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
por: Lee, Dae Ho
Publicado: (2018)

Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
por: Kimura, Yasushi, et al.
Publicado: (2021)

Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy
por: Bonfá, Giuliano, et al.
Publicado: (2020)

Ethical considerations of neuro-oncology trial design in the era of precision medicine
por: Gupta, Saksham, et al.
Publicado: (2017)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Liquid Biopsies in Colorectal Liver Metastases: Towards the Era of Precision Oncologic Surgery
por: Tsilimigras, Diamantis I., et al.
Publicado: (2022)

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019)

An appraisal of drug development timelines in the Era of precision oncology
por: Jardim, Denis Leonardo, et al.
Publicado: (2016)

Corrigendum to Artificial Intelligence in the Era of Precision Oncological Imaging
Publicado: (2023)

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
por: Pabst, Lucile, et al.
Publicado: (2023)

Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020)

Artificial intelligence, molecular subtyping, biomarkers, and precision oncology
por: Shen, John Paul
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hsqsb1dfudsdqor9b99qrv69c2